Project Funding

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 696802. Horizon 2020  has a goal of ensuring that Europe produces world-class science, removes barriers to innovation and makes it easier for the public and private sectors to work together in delivering innovation.

P1vi­tal Products Ltd is sponsoring this research and is the manufacturer of the P1vital® PReDicT Test medical device.

P1vi­tal Ltd is managing the clinical study and specialise in experimental medicine studies for psychiatry and obesity.



Horizon 2020 Emblem